{"result": "(\"entity\"<|>FÓRMULA PEPTÍDICA HC/HP<|>EVENT<|>Fórmula peptídica HC/HP is a nutritional formula providing 1.5kcal/mL, specifically designed for patients with dietary needs, containing 68% fats in the form of MCT.)\n##\n(\"entity\"<|>FÓRMULA POLIMÉRICA HC/HP<|>EVENT<|>Fórmula polimérica HC/HP is a nutritional formula providing 1.5kcal/mL, designed for diabetic patients, with specific macronutrient compositions.)\n##\n(\"entity\"<|>DIABETES<|>GEO<|>Diabetes is a chronic condition that affects how the body processes blood sugar (glucose), influencing dietary requirements and nutritional formulas.)\n##\n(\"entity\"<|>ENFERMEDAD PULMONAR<|>GEO<|>Enfermedad pulmonar refers to chronic lung diseases that can increase energy expenditure and affect nutritional needs.)\n##\n(\"entity\"<|>INSUFICIENCIA PANCREÁTICA EXOCRINA<|>GEO<|>Insuficiencia pancreática exocrina is a condition where the pancreas does not produce enough enzymes for digestion, impacting nutritional absorption.)\n##\n(\"entity\"<|>HEPATOPATÍA RELACIONADA CON LA FQ<|>GEO<|>Hepatopatía relacionada con la FQ refers to liver disease associated with cystic fibrosis, affecting nutrient metabolism.)\n##\n(\"entity\"<|>SÍNDROME DE OBSTRUCCIÓN INTESTINAL DISTAL<|>GEO<|>Sindrome de obstrucción intestinal distal is a condition that can occur in cystic fibrosis patients, leading to digestive complications.)\n##\n(\"entity\"<|>SOBRECRECIMIENTO BACTERIANO<|>GEO<|>Sobrecrecimiento bacteriano refers to an increase in bacteria in the small intestine, which can affect digestion and nutrient absorption.)\n##\n(\"relationship\"<|>FÓRMULA PEPTÍDICA HC/HP<|>DIABETES<|>Fórmula peptídica HC/HP is specifically designed for patients with diabetes, providing tailored nutritional support<|>8)\n##\n(\"relationship\"<|>FÓRMULA POLIMÉRICA HC/HP<|>DIABETES<|>Fórmula polimérica HC/HP is formulated to meet the dietary needs of diabetic patients<|>8)\n##\n(\"relationship\"<|>ENFERMEDAD PULMONAR<|>FÓRMULA PEPTÍDICA HC/HP<|>Fórmula peptídica HC/HP is relevant for patients with chronic lung diseases due to their increased energy needs<|>6)\n##\n(\"relationship\"<|>INSUFICIENCIA PANCREÁTICA EXOCRINA<|>FÓRMULA POLIMÉRICA HC/HP<|>Fórmula polimérica HC/HP is designed to assist patients with pancreatic insufficiency by providing easily digestible nutrients<|>7)\n##\n(\"relationship\"<|>HEPATOPATÍA RELACIONADA CON LA FQ<|>FÓRMULA POLIMÉRICA HC/HP<|>Fórmula polimérica HC/HP can be beneficial for patients with liver disease related to cystic fibrosis, addressing their specific nutritional needs<|>6)\n##\n(\"relationship\"<|>SÍNDROME DE OBSTRUCCIÓN INTESTINAL DISTAL<|>FÓRMULA PEPTÍDICA HC/HP<|>Fórmula peptídica HC/HP may be used in patients with intestinal obstruction to provide necessary nutrition<|>5)\n##\n(\"relationship\"<|>SOBRECRECIMIENTO BACTERIANO<|>FÓRMULA POLIMÉRICA HC/HP<|>Fórmula polimérica HC/HP can help manage nutritional needs in patients with bacterial overgrowth<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 1000mL\n\n\n\n        2012        153,5          42,8       18,2                9                                 =\n                                                                             Fórmula peptídica HC/HP (1,5kcaL/mL)\n        2013        155,5          45,7          18,9            8,1          con 68% de grasas en forma de MCT,1000mL (1500kcaL)\n\n\n\n                                                                            Fórmula polimérica HC/HP (1.5kcaL/ml)\n        2014        155,5          43,5            18           11,7                 específica para diabéticos1000mL al día\n\n\n\n        2015        155,5          42,4          17,5           8,9                                 =\n                                                                            Fórmula polimérica HC/HP (1.5kcaL/ml)\n        2016          156          39,3          16,1          10,3                  específica para diabéticos1500mL al día\n\n\n\n        2017          157          40,5          16,4           8,3                                 =\n                                                                                       Fórmula polimérica HC\n        2018         157,5         42,9          17,3            7,2                 (1.5kcaL/ml) HP específica\n                                                                                      para diabéticos 1000mL\n\n\n\n     Tabla 2: Clasificación de las alteraciones hidrocarbonadas en FQ\n\n\n\n       CATEGORÍA                       GLUCEMIA BASAL                    GLUCEMIA\n                                                                         A LAS 2H DE LA SOG\n       TOLERANCIA NORMAL                < 100 mg/dl                      < 140 mg/dl\n       A LA GLUCOSA                     (5,6 mmol/l)                     (7,8 mmol/l)\n       GLUCEMIA ALTERADA                100-125 mg/dl                         -\n       EN AYUNAS (GBA)                  (5,6-7 mmol/l)\n       TOLERANCIA                       < 100 mg/dl                      < 140 mg/dl (7,8 mmol/l)\n       INDETERMINADA A LA                                                con una glucemia previa\n       GLUCOSA (INDET)                  (5,6 mmol/l)                     > 200 mg/dl (11,1 mmol/l)\n\n\n\n       INTOLERANCIA A LOS               < 100 mg/dl                      Entre 140 y 200 mg/dl\n       HIDRATOS DE                      (5,6 mmol/l)                     (7,8 a 11,1 mmol/l)\n       CARBONO (IHC)\n\n\n\n       DRFQ                             < 126 mg/dl                      > 200 mg/dl\n                                        (7 mmol/l)                       (11,1 mmol/l)\n\n\n\n126\n---\nTabla 3. Causas de desnutrición en FQ\n  AUMENTO DEL                           DISMINUCIÓN                          AUMENTO\n  GASTO ENERGÉTICO                      DE LA INGESTA                        DE LAS PÉRDIDAS\n\n\n\n  ENFERMEDAD PULMONAR:                  ANOREXIA:                            INSUFICIENCIA PANCREÁTICA\n  - Inflamación crónica                 - Infección crónica:                 EXOCRINA\n  - Colonización bacteriana             aumento de producción de moco\n  - Infecciones recurrentes             - Antibióticos\n\n\n\n  INSUFICIENCIA                         REFLUJO                              HEPATOPATÍA RELACIONADA\n  PANCREÁTICA                           GASTROESOFÁGICO                      CON LA FQ: alteración de\n                                                                             sales biliares\n\n\n\n  DEFECTO DEL REGULADOR                 ESTREÑIMIENTO                        DIABETES RELACIONADA\n  DE LA CONDUCTANCIA                                                         CON LA FQ (descompensada)\n  TRANSMEMBRANA\n\n\n\n                                        SÍNDROME DE OBSTRUCCIÓN              SOBRECRECIMIENTO\n                                        INTESTINAL DISTAL                    BACTERIANO\n\n\n\n                                        SOBRECRECIMIENTO\n                                        BACTERIANO\n                                        ALTERACIÓN DE LA\n                                        MOTILIDAD INTESTINAL\n\n\n\nTabla 4. Composición de las diferentes fórmulas de NE\n\n\n\n       COMPOSICIÓN                 FÓRMULA ESTÁNDAR                  FÓRMULA DIABETES                FÓRMULA PEPTÍDICA\n\n\n\n       Aporte de HC                      Alto (>50%)                     Bajo (<50%)                     Alto (50-69%)\n\n\n\n        Tipo de HC                         Sencillos                       Complejos                        Sencillos\n\n\n\n    Índice Glucémico                          Alto                             Bajo                             Alto\n\n\n\n    Aporte de grasa                      Bajo (≈30%)                      Alto (>30%)                    Bajo (15-30%)\n\n\n\n      Tipo de grasa                            LCT                         MUFA, n-3                      MCT (≈70%)\n\n\n\n     Aporte de fibra                     Bajo o nulo                           Alto                            Nulo\n\n\n\n       Tipo de fibra                             -                  Soluble, prebiótico                           -\n\n\n\n         Aporte de                          15-20%                           15-25%                           18-21%\n         proteínas\n                                                                                                            Proteínas\n     Fuente proteica                         Leche                             Soja                        hidrolizadas(péptidos)\n                                                                        Mejor control                     Osmolaridad\n            Otros                        Bajo\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}